Company Overview of BioMarck Pharmaceuticals, Ltd.
BioMarck Pharmaceuticals, Ltd., a biopharmaceutical company, engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. It offers BIO-11006, a dual inhibitor of mucus over-secretion and inflammation that provides a novel approach for the treatment of various respiratory diseases. The company’s products are used by respiratory therapy market. BioMarck Pharmaceuticals was founded in 2002 and is based in Raleigh, North Carolina.
7200 Falls of the Neuse Road
Raleigh, NC 27615
Founded in 2002
Key Executives for BioMarck Pharmaceuticals, Ltd.
Similar Private Companies By Industry
|Rainbow BioScience, LLC||United States|
|St. Renatus, LLC||United States|
|Magellan BioScience Group, Inc.||United States|
|Tapestry Pharmaceuticals||United States|
|DNAtriX, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Pittsburgh W, PA | AstraZenecaPosted: Dec 20
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Oct 22
- Bridgewater, NJ | InformaticaPosted: Dec 11
- Parsippany, NJ | RGPPosted: Dec 13
Sponsored Financial Commentaries
To contact BioMarck Pharmaceuticals, Ltd., please visit www.biomarck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.